Whittier Trust’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.22M Sell
12,787
-1,135
-8% -$421K 0.05% 201
2026
Q1
$4.21M Sell
13,922
-5,331
-28% -$1.75M 0.05% 206
2025
Q4
$7.15M Sell
19,253
-11,972
-38% -$4.05M 0.08% 170
2025
Q3
$10.9M Sell
31,225
-60,732
-66% -$18.9M 0.12% 138
2025
Q2
$35.8M Buy
91,957
+5,345
+6% +$2.15M 0.43% 53
2025
Q1
$37.7M Buy
86,612
+1,687
+2% +$677K 0.52% 45
2024
Q4
$31.3M Sell
84,925
-3,082
-4% -$1.29M 0.41% 51
2024
Q3
$45.8M Sell
88,007
-4,128
-4% -$2.21M 0.61% 39
2024
Q2
$49.9M Sell
92,135
-1,611
-2% -$852K 0.71% 28
2024
Q1
$48.6M Buy
93,746
+1,476
+2% +$734K 0.71% 30
2023
Q4
$43.5M Buy
92,270
+294
+0.3% +$136K 0.71% 32
2023
Q3
$40M Buy
91,976
+1,186
+1% +$538K 0.71% 31
2023
Q2
$40.3M Sell
90,790
-13,170
-13% -$6.08M 0.7% 33
2023
Q1
$47.8M Buy
103,960
+516
+0.5% +$246K 0.87% 24
2022
Q4
$53.1M Buy
103,444
+34
+0% +$17.3K 1.03% 19
2022
Q3
$47M Buy
103,410
+2,025
+2% +$969K 0.98% 19
2022
Q2
$48.9M Buy
101,385
+554
+0.5% +$274K 0.99% 18
2022
Q1
$49.5M Buy
100,831
+1,010
+1% +$462K 0.84% 22
2021
Q4
$46.3M Buy
99,821
+2,125
+2% +$894K 0.75% 26
2021
Q3
$36.4M Sell
97,696
-1,721
-2% -$654K 0.66% 30
2021
Q2
$38M Buy
99,417
+1,761
+2% +$673K 0.68% 32
2021
Q1
$35.1M Buy
97,656
+3,928
+4% +$1.26M 0.68% 33
2020
Q4
$30.1M Buy
93,728
+2,616
+3% +$803K 0.64% 37
2020
Q3
$24.5M Buy
91,112
+1,609
+2% +$433K 0.58% 39
2020
Q2
$23.5M Buy
89,503
+6,518
+8% +$1.74M 0.65% 36
2020
Q1
$18.8M Buy
82,985
+1,548
+2% +$422K 0.62% 36
2019
Q4
$24.6M Buy
81,437
+3,903
+5% +$1.07M 0.65% 35
2019
Q3
$18.6M Buy
77,534
+4,132
+6% +$1.13M 0.53% 46
2019
Q2
$20.7M Buy
73,402
+1,487
+2% +$406K 0.61% 37
2019
Q1
$20.6M Buy
71,915
+4,178
+6% +$1.21M 0.63% 35
2018
Q4
$17.8M Buy
67,737
+10,751
+19% +$2.96M 0.61% 38
2018
Q3
$15.6M Buy
56,986
+1,175
+2% +$305K 0.49% 49
2018
Q2
$13.3M Sell
55,811
-716
-1% -$166K 0.44% 62
2018
Q1
$12.4M Buy
56,527
+1,742
+3% +$409K 0.42% 65
2017
Q4
$12.3M Buy
54,785
+8,352
+18% +$1.78M 0.43% 64
2017
Q3
$8.82M Buy
46,433
+672
+1% +$128K 0.32% 88
2017
Q2
$8.61M Buy
45,761
+828
+2% +$149K 0.33% 87
2017
Q1
$7.43M Buy
44,933
+3,249
+8% +$517K 0.3% 96
2016
Q4
$5.99M Buy
41,684
+920
+2% +$123K 0.25% 108
2016
Q3
$5.11M Sell
40,764
-441
-1% -$56.9K 0.22% 126
2016
Q2
$5.41M Buy
41,205
+1,717
+4% +$235K 0.24% 118
2016
Q1
$5.49M Buy
39,488
+2,883
+8% +$385K 0.24% 119
2015
Q4
$5.1M Buy
36,605
+687
+2% +$94.6K 0.23% 120
2015
Q3
$5.03M Buy
35,918
+1,253
+4% +$188K 0.24% 113
2015
Q2
$5.69M Buy
34,665
+2,004
+6% +$320K 0.25% 108
2015
Q1
$5.04M Buy
32,661
+1,182
+4% +$168K 0.23% 122
2014
Q4
$3.96M Buy
31,479
+219
+0.7% +$27.1K 0.19% 132
2014
Q3
$3.74M Buy
31,260
+752
+2% +$86.3K 0.18% 142
2014
Q2
$3.28M Buy
30,508
+906
+3% +$93.4K 0.16% 147
2014
Q1
$2.95M Buy
29,602
+536
+2% +$48.5K 0.15% 147
2013
Q4
$2.69M Buy
29,066
+85
+0.3% +$7.55K 0.14% 150
2013
Q3
$2.42M Sell
28,981
-35
-0.1% -$3K 0.13% 154
2013
Q2
$2.38M Buy
+29,016
New +$2.17M 0.13% 153

Other funds holding ELV

Whittier Trust's ELV Position: Q2 2026 in Review

Whittier Trust reduced its Elevance Health (ELV) stake by 8.2% in Q2 2026, selling an estimated $421K and leaving 12,787 shares worth $5.22M. The position accounts for 0.05% of the portfolio, ranked #201.

Whittier Trust first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. The position peaked at $53.1M in Q4 2022. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Whittier Trust held 12,787 shares of Elevance Health worth $5.22M as of Q2 2026.
  • Whittier Trust sold 1,135 Elevance Health shares in Q2 2026, an estimated $421K.
  • Elevance Health made up 0.05% of Whittier Trust's portfolio in Q2 2026, its #201 holding.
  • Whittier Trust first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
  • Whittier Trust's Elevance Health position peaked at $53.1M in Q4 2022.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Whittier Trust's 13F filing for Q2 2026, filed 28 Jul 2026.